ABSTRACT Systemic nocardiosis is rarely reported in patients with systemic vasculitis, and is mostly described in patients experiencing long-term immunosuppression following organ transplantation. In this report, we describe a 71-year-old man who developed disseminated Nocardia infection during treatment of his underlying microscopic polyangiitis. He had no other associated risk factors. This case highlights the importance of considering rare pathogens in immunosuppressed patients who present with nonspecific symptoms, as well as the impact of such pathogens on clinical management.
I NTRO D U C TIO N
The clinical presentation of nocardiosis is primarily pulmonary, with reported identification in cases of necrotising pneumonia, empyema and lung abscesses. (4) However, other manifestations, such as cutaneous or cerebral infection with cellulitic nodular changes and abscesses that lead to space-occupying, lesion-like presentations, have also been documented in the literature. (5, 6) The primary challenge with nocardiosis is in arriving at a diagnosis. Although well-reported in the medical literature, the relative rarity of this infection can lead to it being overlooked and misdiagnosed as other pathologies. 
CA S E R EPO RT
A 71-year-old man with a history of psoriasis and hypertension (Table I) ; thus a diagnosis of MPA was made. The patient's renal function subsequently improved and there was radiological resolution of the signs, leading to his discharge from the intensive treatment unit after three weeks.
Three months after the patient's emergency admission, he relapsed with progressive shortness of breath and a productive cough. Chest radiography and CT revealed previously unseen cavitating lesions in the left mid-zone of the chest (Fig. 3 ).
Bronchoalveolar lavage was performed and the washout showed high titres of CMV (216,000 copies/mL), which was associated with a marginal elevation in serum CMV DNA PCR (4,000 copies/mL). By the time the CMV DNA PCR result was obtained, treatment with valgancyclovir had already commenced on the basis of clinical suspicion. As the cavitating lesions raised the suspicion of either cavitating pulmonary 
D I SCU S S IO N
Disseminated nocardiosis has not been reported in patients with systemic vasculitis, especially MPA, even in large studies.
Randomised European trials in vasculitis have not reported
Nocardia infection in their study patients. (9) As such, little is known about the outcome of this condition. Nocardiosis has, however, been described in patients with non-Hodgkin's lymphoma and in renal transplant patients following rituximab therapy. (10, 11) Our report describes the first case of MPA complicated by systemic nocardiosis that was successfully treated.
Nocardia spp. are ubiquitous environmental micro-organisms belonging to a diverse group of Actinomycetes. (12, 13) In the majority of cases, Nocardia infection is opportunistic, targeting immunocompromised patients such as those who are on long-term steroids and HIV-positive, as well as chemotherapy or post-organ transplantation patients. (14) Patients who have undergone kidney, heart or liver transplantation are most commonly affected. (15) Infection with CMV has also been described as a cofactor in the development of nocardiosis, as seen in our case, in which CMV performed an important immunomodulatory role in the development of nocardiosis.
One matched case-control study (2) The presence of simultaneous lung and brain abscesses has been documented as a reliable indication of an underlying Nocardia infection. (16) Although our patient was asymptomatic, the MR imaging findings were consistent with characteristics that have been noted in past studies. (17, 18) This leads to the dilemma of whether patients undergoing immunosuppressive therapy should be screened early for nocardiosis, especially if they present with nonspecific symptoms.
In our patient, nocardiosis was caused by Nocardia nova, which was sensitive to co-trimoxazole and imipenum. Six weeks of treatment with these antibiotics led to complete clinical and radiological recovery in the patient. However, the asymptomatic brain involvement proved challenging, requiring carefully selected antibiotics with high cerebrospinal fluid penetration and prolonged treatment with co-trimoxazole. Serial MR imaging of our patient's brain showed gradual improvement in the size of the intracranial lesion as treatment progressed.
In conclusion, the incidence of nocardiosis in patients with vasculitis and its prognosis with treatment remain unclear. Our case is unique on two accounts -it is the first reported case of systemic infection in MPA, and the patient experienced rapid 
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